Pancreatic Cancer Research

ResearcherFirst Affiliated Hospital of Xi'an Jiaotong UniversityNo recent work listed

Junyu Cao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-0123-5656; OpenAlex author ID A5038040398. Sources: OpenAlex.

Their work

Papers
13 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
26
Papers, trials and grants by year

2017: 2 papers · 2018: 7 papers · 2019: 4 papers

Papers 13

  1. Hypoxia-driven paracrine osteopontin/integrin αvβ3 signaling promotes pancreatic cancer cell epithelial-mesenchymal transition and cancer stem cell-like proper… Co-author DOI 10.1002/1878-0261.12399↗
  2. Mouse-Derived Allografts: A Complementary Model to the KPC Mice on Researching Pancreatic Cancer In Vivo. Co-author DOI 10.1016/j.csbj.2019.03.016↗
  3. Resveratrol enhances the chemotherapeutic response and reverses the stemness induced by gemcitabine in pancreatic cancer cells via targeting SREBP1. Co-author DOI 10.1111/cpr.12514↗
  4. Betulinic acid inhibits stemness and EMT of pancreatic cancer cells via activation of AMPK signaling. First author DOI 10.3892/ijo.2018.4604↗
  5. Targeting glypican-4 overcomes 5-FU resistance and attenuates stem cell-like properties via suppression of Wnt/β-catenin pathway in pancreatic cancer cells. Co-author DOI 10.1002/jcb.27266↗
  6. Metformin suppresses tumor angiogenesis and enhances the chemosensitivity of gemcitabine in a genetically engineered mouse model of pancreatic cancer. Co-author DOI 10.1016/j.lfs.2018.07.046↗
  7. Paracrine HGF/c-MET enhances the stem cell-like potential and glycolysis of pancreatic cancer cells via activation of YAP/HIF-1α. Co-author DOI 10.1016/j.yexcr.2018.07.041↗
  8. Resveratrol-Induced Downregulation of NAF-1 Enhances the Sensitivity of Pancreatic Cancer Cells to Gemcitabine via the ROS/Nrf2 Signaling Pathways. Co-author DOI 10.1155/2018/9482018↗
  9. Overexpression of Gremlin 1 by sonic hedgehog signaling promotes pancreatic cancer progression. Co-author DOI 10.3892/ijo.2018.4573↗
  10. Metformin suppresses the invasive ability of pancreatic cancer cells by blocking autocrine TGF‑β1 signaling. Co-author DOI 10.3892/or.2018.6518↗
  11. Norepinephrine enhances cell viability and invasion, and inhibits apoptosis of pancreatic cancer cells in a Notch‑1‑dependent manner. Co-author DOI 10.3892/or.2018.6696↗
  12. Loss of AMPK activation promotes the invasion and metastasis of pancreatic cancer through an HSF1-dependent pathway. Co-author DOI 10.1002/1878-0261.12116↗
  13. Metformin suppresses cancer initiation and progression in genetic mouse models of pancreatic cancer. Co-author DOI 10.1186/s12943-017-0701-0↗

Closest collaborators

The 25 strongest of 26 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Qingyong Ma · 13 shared papers, 2017–2019 · strength 0.98
  2. Weikun Qian · 13 shared papers, 2017–2019 · strength 0.98
  3. Liang Cheng · 12 shared papers, 2017–2019 · strength 0.90
  4. Cancan Zhou · 11 shared papers, 2017–2019 · strength 0.80
  5. Wanxing Duan · 9 shared papers, 2017–2019 · strength 0.66
  6. Bin Yan · 9 shared papers, 2017–2019 · strength 0.66
  7. Jiguang Ma · 8 shared papers, 2017–2019 · strength 0.60
  8. Liankang Sun · 8 shared papers, 2017–2019 · strength 0.58
  9. Ke Chen · 8 shared papers, 2017–2019 · strength 0.58
  10. Jie Li · 7 shared papers, 2017–2019 · strength 0.52
  11. Zhengdong Jiang · 7 shared papers, 2017–2019 · strength 0.50
  12. Ying Xiao · 4 shared papers, 2018–2019 · strength 0.33
  13. Tao Qin · 4 shared papers, 2018–2019 · strength 0.33
  14. Erxi Wu · 3 shared papers, 2018–2019 · strength 0.23
  15. Zheng Wu · 2 shared papers, 2019 · strength 0.18
  16. Jianjun Lei · 2 shared papers, 2018–2019 · strength 0.16
  17. Liang Han · 2 shared papers, 2018–2019 · strength 0.15
  18. Xuqi Li · 2 shared papers, 2018–2019 · strength 0.15
  19. Qinhong Xu · 2 shared papers, 2018–2019 · strength 0.15
  20. Zheng Wang · 1 shared paper, 2019 · strength 0.08
  21. Yongtian Yu · 1 shared paper, 2018 · strength 0.08
  22. Liang Han · 1 shared paper, 2018 · strength 0.08
  23. Huanchen Sha · 1 shared paper, 2018 · strength 0.07
  24. Tao Qin · 1 shared paper, 2018 · strength 0.07
  25. Zheng Wang · 1 shared paper, 2018 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.